By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ocular Therapeutix, Inc. 

204 Second Avenue

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-895-3235 Fax: 781-895-3236


SEARCH JOBS


Industry
Biotechnology






Company News
Ocular Therapeutix (OCUL) Presented Phase III Data For DEXTENZA At Association for Research in Vision & Ophthalmology Annual Meeting 5/11/2017 8:29:10 AM
Ocular Therapeutix (OCUL) Presents Preclinical Data On Pharmacokinetics, Efficacy And Tolerability Of Sustained Release Intravitreal Tyrosine Kinase Inhibitor Hydrogel Depot (OTX-TKI) At The Association for Research in Vision & Ophthalmology Annual Meeting 5/10/2017 7:50:12 AM
Ocular Therapeutix (OCUL) Presents Additional Phase III Data And Patient Reported Outcomes Results For DEXTENZA At American Society of Cataract & Refractive Surgery Symposium 5/8/2017 7:50:28 AM
Ocular Therapeutix (OCUL) Reports First Quarter 2017 Financial Results 5/5/2017 6:05:26 AM
Ocular Therapeutix (OCUL) To Present Data On Anterior And Posterior Segment Drug Product Candidates At Association for Research in Vision & Ophthalmology Annual Meeting 5/2/2017 7:58:11 AM
Ocular Therapeutix (OCUL) To Report First Quarter 2017 Financial Results 5/2/2017 6:34:01 AM
Ocular Therapeutix (OCUL) To Present Additional Phase III Data And Patient Reported Outcomes Results For DEXTENZA At American Society of Cataract & Refractive Surgery Symposium 4/24/2017 7:58:20 AM
Ocular Therapeutix (OCUL) Appoints George Migausky As Interim Chief Financial Officer 4/6/2017 8:21:09 AM
New Publication Describes Positive Patient Experience In Study Of Ocular Therapeutix (OCUL)’s DEXTENZA Following Cataract Surgery 3/15/2017 6:48:52 AM
Ocular Therapeutix (OCUL) Reports Fourth Quarter And Full Year 2016 Financial Results 3/10/2017 6:29:23 AM
12345678910...
//-->